Cancer survivors, especially those treated for head and neck cancers, often face speech and swallowing difficulties. Speech-language therapy plays a major role in helping them regain communication ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial ...